Search clinical trials for: Dosing Interruption of Natalizumab
Total 1668 results
-
Berkovich, Regina MD, PhD Inc.Biogen; Cedars-Sinai Medical CenterRecruitingMultiple Sclerosis | Multiple Sclerosis, Relapsing-RemittingUnited States
-
Amsterdam UMC, location VUmcInnovatiefonds Zorgverzekeraars; Stichting MS Research; Stichting TreatmedsEnrolling by invitationRelapsing Remitting Multiple SclerosisNetherlands
-
BiogenElan Pharmaceuticals; United BioSource, LLCCompleted
-
UConn HealthColgate PalmoliveCompleted
-
BiogenElan PharmaceuticalsWithdrawn
-
BiogenElan PharmaceuticalsCompletedCrohn's DiseaseUnited States
-
BiogenElan PharmaceuticalsCompleted
-
BiogenElan PharmaceuticalsCompletedCrohn's DiseaseUnited States
-
BiogenElan PharmaceuticalsCompletedCrohn's DiseaseUnited States, United Kingdom
-
University at BuffaloCompleted
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisFrance, Italy, Spain, Germany, Belgium
-
University Hospital, CaenBiogenCompletedMultiple Sclerosis, Relapsing-RemittingFrance
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisIreland
-
BiogenTerminatedSecondary Progressive Multiple SclerosisUnited States, Finland, Italy, Spain, Canada, France, Israel, Sweden, Netherlands, Belgium, Poland, United Kingdom, Czechia, Denmark, Russian Federation, Germany, Ireland
-
BiogenElan PharmaceuticalsCompleted
-
BiogenCompletedRelapsing-Remitting Multiple Sclerosis
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisBelgium, Germany, Italy, Norway, France, Mexico, Australia, Spain, Portugal, Greece, Netherlands, United Kingdom, Czechia, Slovakia, Finland, Canada, Argentina, Brazil
-
BiogenCompletedAcute Ischemic StrokeSpain, United States, Germany, United Kingdom
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisCzechia, Belgium
-
BiogenTerminated
-
University of California, San FranciscoUniversitywide AIDS Research ProgramCompletedHIV InfectionsUnited States
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited States
-
BiogenCompleted
-
BiogenTerminatedRelapsing Multiple SclerosisBelgium
-
BiogenTerminatedCrohn's DiseaseUnited States, Puerto Rico
-
Cornerstone Health Care, PABiogenCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
BiogenElan PharmaceuticalsTerminated
-
BiogenTerminatedRelapsing Multiple SclerosisUnited States
-
University of South FloridaCompletedMultiple SclerosisUnited States
-
BiogenElan PharmaceuticalsCompletedRelapsing Remitting Multiple Sclerosis (RRMS)Belgium, Mexico, Poland, Romania, Saudi Arabia, Ukraine
-
BiogenCompletedRelapsing Multiple SclerosisUnited States, Puerto Rico
-
Virginia Commonwealth UniversityNational Institutes of Health (NIH); American Lung AssociationTerminatedDepression | Quality of Life | Sedation | Post-traumatic Stress Disorder | Mechanical Ventilation
-
BiogenCompletedAcute Ischemic StrokeSpain, United States, Germany
-
BiogenElan PharmaceuticalsCompletedCrohn's DiseaseUnited States, Canada
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisJapan
-
BiogenCompletedRelapsing Forms of Multiple SclerosisUnited States
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Swiss Federal Institute of TechnologyUniversity of Michigan; University of Lausanne; University of Turin, ItalyCompletedMuscle Fatigue | Trapezius Muscle Strain
-
BiogenCompleted
-
BiogenElan PharmaceuticalsCompleted
-
Nantes University HospitalRennes University HospitalActive, not recruiting
-
University College Hospital GalwayStewart R Walsh; Wael Tawfick; Thomas A Aherne; Mark Twyford; Marie O'ShaughnessyRecruiting
-
BiogenElan PharmaceuticalsCompletedCrohn's DiseaseUnited States
-
Vanderbilt University Medical CenterBiogenTerminated
-
BiogenElan PharmaceuticalsTerminatedRheumatoid ArthritisUnited States, Canada
-
BiogenCompletedProgressive Multifocal LeukoencephalopathyUnited States
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited States
-
BiogenRecruiting